Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.93−0.08 (-3.98%)
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
Ernexa Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Ernexa Therapeutics's operating margin for the twelve months ending Dec 31, 2024 was -2693.1%. For fiscal 2024 it was -2693.1%, against -31080.9% the year before. The highest annual figure on record is 0.9% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -2693.1% | +28387.8 |
| FY2023 | Dec 31, 2023 | -31080.9% | −30955.9 |
| FY2020 | Dec 31, 2020 | -125.0% | −116.1 |
| FY2019 | Dec 31, 2019 | -8.9% | −9.8 |
| FY2018 | Dec 31, 2018 | 0.9% | +7.5 |
| FY2017 | Dec 31, 2017 | -6.6% | +3.6 |
| FY2016 | Dec 31, 2016 | -10.2% | +17.9 |
| FY2015 | Dec 31, 2015 | -28.1% | −9.9 |
| FY2014 | Dec 31, 2014 | -18.2% | −13.5 |
| FY2013 | Dec 31, 2013 | -4.7% | −0.3 |
| FY2012 | Dec 31, 2012 | -4.4% | +9.3 |
| FY2011 | Dec 31, 2011 | -13.7% | −12.4 |
| FY2010 | Dec 31, 2010 | -1.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -269700.0% | −235788.2 |
| Q3 FY2024 | Sep 30, 2024 | -463.9% | +10330.3 |
| Q2 FY2024 | Jun 30, 2024 | -10491.5% | −10303.7 |
| Q1 FY2024 | Mar 31, 2024 | -12312.8% | −12176.8 |
| Q4 FY2023 | Dec 31, 2023 | -33911.8% | −33644.0 |
| Q3 FY2023 | Sep 30, 2023 | -10794.1% | −10751.7 |
| Q4 FY2020 | Dec 31, 2020 | -187.8% | −164.1 |
| Q3 FY2020 | Sep 30, 2020 | -135.9% | −129.0 |
| Q2 FY2020 | Jun 30, 2020 | -267.8% | −267.8 |
| Q1 FY2020 | Mar 31, 2020 | -42.4% | −37.9 |
| Q4 FY2019 | Dec 31, 2019 | -23.7% | −26.7 |
| Q3 FY2019 | Sep 30, 2019 | -6.9% | −13.1 |
| Q2 FY2019 | Jun 30, 2019 | -0.0% | +0.4 |
| Q1 FY2019 | Mar 31, 2019 | -4.5% | +0.9 |
| Q4 FY2018 | Dec 31, 2018 | 2.9% | +12.2 |
| Q3 FY2018 | Sep 30, 2018 | 6.2% | +7.2 |
| Q2 FY2018 | Jun 30, 2018 | -0.5% | −0.0 |
| Q1 FY2018 | Mar 31, 2018 | -5.4% | +10.5 |
| Q4 FY2017 | Dec 31, 2017 | -9.2% | −4.2 |
| Q3 FY2017 | Sep 30, 2017 | -1.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -0.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -15.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -5.0% | – |
See a number that looks wrong?